GO:0032006 regulation of TOR signaling: Signaling Control Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032006 (regulation of TOR signaling) is a biological process that modulates the frequency, rate or extent of TOR signaling, the conserved pathway centered on the TOR kinase.
• TOR signaling is regulated by nutrients, growth factors, calcium-binding proteins, lysosomal cues and gut microbiota-derived signals, making it a central hub for cell growth and metabolism.
• Dysregulation of TOR signaling is linked to cancer, metabolic disease and impaired autophagy, and epigenetic and non-coding RNA mechanisms feed into this control.
• Key regulators include PI3K/PTEN, TFEB, Ca2+-binding proteins, GAS5 and TOR itself, which together tune downstream anabolic and catabolic programs.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to test causality of candidate regulators of TOR signaling.
• Studying GO:0032006 requires combining genetic perturbation with phospho-signaling assays, transcriptomics, proteomics and imaging to resolve context-dependent effects.
Description
Regulation of TOR signaling (GO:0032006) describes any process that modulates the frequency, rate or extent of TOR signaling, the evolutionarily conserved pathway governed by the target of rapamycin kinase. Because TOR integrates nutrient, energy, growth-factor and stress inputs, its regulation determines whether cells grow, proliferate, recycle components through autophagy or enter quiescence. Researchers study this term to understand how upstream cues are converted into downstream phosphorylation events and how misregulation contributes to disease. The pathway is conserved from plants to mammals, and its regulation involves calcium-binding proteins, lysosomal signaling to the nucleus, and crosstalk with PI3K/PTEN homeostasis. In plants, TOR is a multidimensional regulator of growth and signaling, underscoring the broad relevance of GO:0032006 across kingdoms. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to explain what happens during regulation of TOR signaling, which genes are involved, and how CRISPR-based models can be used to interrogate it.
regulation of TOR signaling At A Glance
| GO ID | GO:0032006 |
|---|---|
| GO term | regulation of TOR signaling |
| Ontology | biological_process |
| Synonym | regulation of target of rapamycin signaling pathway; regulation of TOR signaling cascade; regulation of TOR signaling pathway |
| Major function | Modulates the frequency, rate or extent of TOR signaling in response to nutrients, growth factors, calcium and lysosomal cues |
| Conservation | Conserved from plants to mammals, with TOR controlling growth and signaling in plants and animals |
| Key upstream inputs | PI3K/PTEN signaling, Ca2+-binding proteins, lysosomal status, gut microbiota-derived signals |
| Disease relevance | Cancer, metabolic dysregulation and autophagy-related pathology |
What Is GO:0032006?
GO:0032006 (regulation of TOR signaling) is defined by QuickGO as any process that modulates the frequency, rate or extent of TOR signaling. In practical terms, it covers the upstream and feedback mechanisms that set the intensity, duration and location of TOR kinase activity and its downstream outputs, rather than the core signaling reactions themselves.
Why Is regulation of TOR signaling Important in Cell Biology?
Regulation of TOR signaling is important because it determines how cells allocate resources between growth and catabolism, and its perturbation is a recurring theme in cancer, metabolic disease and autophagy-related disorders. Because TOR responds to diverse inputs including calcium, lysosomal status and microbiota-derived signals, understanding GO:0032006 provides a framework for interpreting context-specific signaling outcomes.
• Controls the balance between anabolic growth and autophagic degradation.
• Integrates nutrient, growth-factor and calcium signals into a single regulatory hub.
• Links lysosomal status to nuclear transcriptional programs via TFEB.
• Is modulated by gut microbiota, connecting the microbiome to host signaling.
• Is epigenetically regulated in hepatocellular carcinoma progression.
• Involves non-coding RNA control, exemplified by GAS5-mediated regulation of cell signaling.
• Requires PI3K/PTEN feedback to maintain pathway homeostasis.
• Is conserved in plants, where TOR coordinates growth and signaling pathways.
• Provides therapeutic targets for cancer and metabolic disease.
• Demands rigorous genetic models to distinguish causal regulators from correlative changes.
What Happens During regulation of TOR signaling?
Upstream input sensing
In simple terms: The cell first checks whether nutrients, growth factors and calcium levels are suitable before activating TOR.
Regulation of TOR signaling begins with sensing of extracellular and intracellular cues. Growth-factor signaling through PI3K and PTEN sets the tone of the pathway, and PI3K signaling regulates PTEN translation to maintain pathway homeostasis. Calcium-binding proteins provide an additional layer of control over mTOR signaling, linking calcium status to TOR activity. In the gut, microbiota-derived signals interact with mTOR signaling, illustrating how environmental inputs feed into this regulatory node.
Lysosomal and nuclear crosstalk
In simple terms: The lysosome communicates with the nucleus to tell the cell whether to recycle or build.
A lysosome-to-nucleus signaling mechanism senses and regulates the lysosome via mTOR and TFEB, so that lysosomal status is transmitted to transcriptional programs. This crosstalk is a core component of GO:0032006 because it adjusts TOR output according to the degradative capacity of the cell. Autophagy regulation by the mTOR signaling pathway is intimately tied to this lysosomal sensing arm.
Non-coding RNA and epigenetic modulation
In simple terms: RNAs and epigenetic marks can dial TOR signaling up or down.
GAS5-mediated regulation of cell signaling illustrates how long non-coding RNAs modulate signaling pathways, including TOR-related outputs. Epigenetic regulation of hepatocellular carcinoma progression through the mTOR signaling pathway shows that chromatin-level mechanisms can shape the intensity of TOR signaling. These layers expand the regulatory repertoire of GO:0032006 beyond classical kinase cascades.
Downstream effector tuning
In simple terms: Once TOR is active, it adjusts protein synthesis, autophagy and growth programs.
Downstream of TOR, the pathway controls autophagy and related catabolic processes, as reviewed for the mTOR signaling pathway. In plants, TOR acts as a multidimensional regulator of growth and signaling pathways, demonstrating conservation of downstream tuning. The net output of GO:0032006 is therefore a context-dependent balance between synthesis and degradation.
Feedback and homeostasis
In simple terms: The pathway monitors itself so it does not stay switched on or off for too long.
Feedback control is essential: PI3K signaling regulates PTEN translation to maintain pathway homeostasis, preventing runaway activation. Calcium-binding proteins add another feedback layer that fine-tunes mTOR signaling. Together these mechanisms ensure that regulation of TOR signaling remains dynamic and responsive.
Key Genes Involved in GO:0032006 regulation of TOR signaling
The following genes and proteins are central to regulation of TOR signaling (GO:0032006), based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Core TOR kinase whose signaling is regulated | Central node of GO:0032006 and target of autophagy studies |
| PIK3CA | PI3K catalytic subunit upstream of TOR | Links growth-factor signaling to TOR regulation |
| PTEN | Phosphatase that restrains PI3K signaling | Its translation is regulated by PI3K to maintain homeostasis |
| TFEB | Transcription factor downstream of lysosomal mTOR signaling | Mediates lysosome-to-nucleus signaling |
| GAS5 | Long non-coding RNA regulating cell signaling | Modulates TOR-related signaling outputs |
| CALM1 | Calcium-binding protein | Calcium-dependent regulation of mTOR signaling |
| CALM2 | Calcium-binding protein | Calcium-dependent regulation of mTOR signaling |
| CALM3 | Calcium-binding protein | Calcium-dependent regulation of mTOR signaling |
| RPTOR | mTOR complex component | Scaffolds TOR complexes relevant to regulation |
| RICTOR | mTOR complex component | Contributes to context-specific TOR outputs |
| AKT1 | Kinase upstream of TOR | Connects growth-factor cues to TOR regulation |
| TSC1 | Negative regulator of TOR signaling | Restrains TOR in response to stress |
| TSC2 | Negative regulator of TOR signaling | Restrains TOR in response to stress |
| RHEB | Activator of TOR | Directly stimulates TOR kinase activity |
| LAMP1 | Lysosomal marker | Used to study lysosomal mTOR signaling |
| SQSTM1 | Autophagy receptor | Readout of TOR-regulated autophagy |
| MAP1LC3B | Autophagosome marker | Readout of TOR-regulated autophagy |
How Is regulation of TOR signaling Regulated?
Regulation of TOR signaling is itself regulated at multiple levels. PI3K signaling controls PTEN translation to maintain pathway homeostasis, creating a feedback loop that prevents excessive or insufficient TOR activity. Calcium-binding proteins modulate mTOR signaling in response to calcium fluctuations. Lysosomal status is relayed to the nucleus through mTOR and TFEB, allowing transcriptional adaptation. Non-coding RNAs such as GAS5 and epigenetic mechanisms further tune the pathway in disease contexts. In plants, TOR integrates growth and signaling inputs, showing that regulatory logic is conserved.
regulation of TOR signaling and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Cancer and autophagy-related disease | Knockout and point-mutation cell models |
| PTEN | Cancer and pathway homeostasis | Knock-in and overexpression models |
| TFEB | Lysosomal and metabolic disease | Knockout and tagged knock-in models |
| GAS5 | Cancer signaling dysregulation | Overexpression and knockout models |
| PIK3CA | Oncogenic signaling | Point-mutation knock-in models |
Cancer
Epigenetic regulation of hepatocellular carcinoma progression through the mTOR signaling pathway demonstrates that altered regulation of TOR signaling contributes to tumor biology. PI3K/PTEN feedback mechanisms that maintain pathway homeostasis are frequently perturbed in cancer, making GO:0032006 a relevant area for oncogenic signaling research.
Autophagy-related and metabolic disorders
Because the mTOR signaling pathway regulates autophagy, dysregulation of GO:0032006 can impair autophagic clearance and contribute to metabolic and degenerative phenotypes. Lysosome-to-nucleus signaling via mTOR and TFEB links TOR regulation to lysosomal storage and related disorders.
Microbiome-associated pathology
Gut microbiota and mTOR signaling interact, suggesting that microbiome-derived signals can influence host TOR regulation and thereby contribute to pathophysiological states.
Non-coding RNA-linked disease
GAS5-mediated regulation of cell signaling highlights how lncRNA dysregulation can alter TOR-related pathways in disease.
From regulation of TOR signaling-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for TOR regulation? | CRISPR knockout cell model |
| Does a specific mutation alter TOR signaling? | Point-mutation knock-in model |
| How does a tag affect pathway readouts? | Tagged knock-in model |
| Does overexpression drive TOR output? | Overexpression cell model |
| Which regulators are causal in disease? | Library screening with CRISPR |
| How does calcium input affect TOR? | Knockout of calcium-binding proteins |
How to Study the regulation of TOR signaling Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | Phosphorylation of TOR substrates | Pathway activation status |
| RNA-seq | Transcriptional changes | TFEB and autophagy gene programs |
| Proteomics | Protein abundance and modifications | Mapping regulatory networks |
| Immunofluorescence | Autophagosome and lysosome markers | Autophagy flux readout |
| CRISPR screening | Gene requirement in pathway | Identifying regulators |
| qPCR | Expression of pathway genes | Validating perturbations |
| Co-immunoprecipitation | Protein-protein interactions | Complex composition |
Phospho-signaling assays
Western blotting for phosphorylated TOR substrates is a standard way to measure the output of GO:0032006 after genetic perturbation.
Transcriptomics and RNA-seq
RNA-seq can reveal how regulation of TOR signaling reshapes transcriptional programs, including TFEB-dependent lysosomal and autophagy genes.
Proteomics and interactomics
Proteomic approaches identify proteins whose abundance or modification changes when TOR regulation is altered, helping map the pathway.
Imaging and autophagy flux
Fluorescence imaging of autophagosomes and lysosomes, combined with markers such as MAP1LC3B, visualizes the downstream consequences of TOR regulation.
How CRISPR Can Be Used to Study GO:0032006 regulation of TOR signaling
Knockout
CRISPR knockout of candidate regulators such as MTOR, PTEN or TFEB allows researchers to test whether a gene is required for regulation of TOR signaling and its downstream autophagy outputs.
Point Mutation
Point-mutation knock-in can model specific residues in PI3K or PTEN to dissect how individual phosphorylation or catalytic events affect TOR regulation.
Knock-in
Tagged knock-in of TFEB or mTOR complex components enables localization and interaction studies that reveal where regulation of TOR signaling occurs within the cell.
Overexpression
Overexpression of non-coding RNAs such as GAS5 or of pathway activators can test sufficiency for altering TOR signaling in disease-relevant contexts.
How EDITGENE Supports regulation of TOR signaling Research
Researchers studying regulation of TOR signaling-related genes often need to determine whether a candidate gene is causally involved in modulating the pathway or merely correlated with its activity. EDITGENE provides the CRISPR tools and bioinformatics support required to move from hypothesis to validated mechanism in GO:0032006 research.
Contact EDITGENE today to design your custom CRISPR model for regulation of TOR signaling research.
Frequently Asked Questions About regulation of TOR signaling
What is regulation of TOR signaling (GO:0032006)?
It is any process that modulates the frequency, rate or extent of TOR signaling, the conserved pathway centered on the TOR kinase.
What genes are involved in regulation of TOR signaling?
Key genes include MTOR, PIK3CA, PTEN, TFEB, GAS5 and calcium-binding proteins such as CALM1-3.
How is TOR signaling regulated by nutrients and calcium?
Calcium-binding proteins modulate mTOR signaling, while nutrient and growth-factor cues act through PI3K/PTEN and lysosomal sensing.
Why is regulation of TOR signaling important in cancer?
Epigenetic regulation of hepatocellular carcinoma progression through mTOR signaling shows that altered TOR regulation contributes to tumor biology.
How does mTOR regulate autophagy?
The mTOR signaling pathway regulates autophagy, and its control is a major downstream output of GO:0032006.
What is the role of TFEB in TOR signaling?
TFEB mediates lysosome-to-nucleus signaling downstream of mTOR, linking lysosomal status to transcription.
Does the gut microbiota affect TOR signaling?
Yes, gut microbiota and mTOR signaling interact, indicating that microbial signals can influence host TOR regulation.
How do non-coding RNAs regulate TOR signaling?
GAS5-mediated regulation of cell signaling demonstrates that lncRNAs can modulate TOR-related pathways.
Is TOR signaling conserved in plants?
Yes, TOR in plants acts as a multidimensional regulator of growth and signaling pathways.
How can CRISPR help study regulation of TOR signaling?
CRISPR knockout, point-mutation, knock-in and overexpression models test causality of candidate regulators in GO:0032006.
Conclusion
Regulation of TOR signaling (GO:0032006) is a central biological process that integrates nutrient, growth-factor, calcium, lysosomal and microbiome-derived inputs to set the balance between growth and catabolism. Its dysregulation is implicated in cancer, autophagy-related and metabolic disease, and non-coding RNA or epigenetic mechanisms add further layers of control. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with phospho-signaling, transcriptomic, proteomic and imaging readouts, provide the experimental toolkit needed to dissect this pathway.
References
- 1. Noureldein MH et al.. 2018. Gut microbiota and mTOR signaling: Insight on a new pathophysiological interaction.. Microb Pathog 118:98-104 PMID: 29548696
- 2. Zhou Y et al.. 2020. GAS5‑mediated regulation of cell signaling (Review).. Mol Med Rep 22(4):3049-3056 PMID: 32945519
- 3. Wang Y et al.. 2019. Regulation of Autophagy by mTOR Signaling Pathway.. Adv Exp Med Biol 1206:67-83 PMID: 31776980
- 4. Amemiya Y et al.. 2023. New Insights into the Regulation of mTOR Signaling via Ca(2+)-Binding Proteins.. Int J Mol Sci 24(4) PMID: 36835331
- 5. Rabeh K et al.. 2024. TOR in plants: Multidimensional regulators of plant growth and signaling pathways.. J Plant Physiol 294:154186 PMID: 38330538
- 6. Mukherjee R et al.. 2021. Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis.. Mol Cell 81(4):708-723.e5 PMID: 33606974
- 7. Settembre C et al.. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB.. EMBO J 31(5):1095-108 PMID: 22343943
- 8. Guo M et al.. 2021. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway.. Can J Gastroenterol Hepatol 2021:5596712 PMID: 34123955
